Efficacy of Vitamin B6 on Pregnancy Outcomes: A Randomized Clinical Trial
Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 19, Issue 1
Abstract
Background: Postpartum depression is a common and disabling disorder. A low level of vitamin B6 might theoretically causes symptoms of depression. The aim of this study was to investigate the effect of vitamin B6 on Pregnancy outcomes among the mothers at risk for postpartum depression during third trimester. Methods: A single blind randomized clinical trial was conducted via using B6 and placebo on 86 at risk postpartum depression pregnant subjects at six selected health center in Isfahan, Iran with a simple random sampling method (Feb-July, 2016). The main inclusion criteria in this study was at least a risk factor of postpartum depression; evaluated by Hospital Anxiety-Depressive Scale, Social Support Appraisals Scale, Holmes and Rahe Life Change and Stress Evaluation Questioner. Data was analyzed applying SPSS20 and statistical tests (chi-square, t-test, Mann-Whitney, Fisher’s exact test). Results: In case group after intervention mean depression score was (4.2±2.7) significantly lower than before intervention (10.4±1.4) (p<0/001) Control group mean depression score was no significant difference after (10.4±3.4) and before intervention (9.3±4.2) (p= 0.10). Mean maternal weight gain (P=0.32), delivery type (P=0.56), infant birth weight (P=0.37), gestational age (P=0.31) were not significant difference between two groups. Conclusion: Vitamin B6 may have a positive effect to decreasing of postpartum depression score, and no effects on another pregnancy outcome.
Authors and Affiliations
Maryam Khodadad, Gholamreza Kheirabadi, Parvin Bahadoran
Keywords
Related Articles
- EP ID EP313036
- DOI 10.9734/JPRI/2017/32675
- Views 111
- Downloads 0
UPLC-MS/MS Determination of Aceclofenac and Diclofenac in Bulk, Dosage forms and in At-line Monitoring of Aceclofenac Synthesis
Aim: The derivatization product of diclofenac (DCL), aceclofenac (ACL), is a non-steroidal anti-inflammatory drug (NSAID) which causes faster and extended action with reduced gastrointestinal (GI) inflammation. The detec...
Effect of Chelidonium majus on Metabolic Abnormalities Induced by HAART in Mice
Aims: Extracts of Chelidonium majus, extensively used in traditional systems of medicine, have been tested for their possible anti-tumor, hepato-protective and anti-genotoxic effects, to investigate their potential in ca...
Clinical Outcome Evaluation of Glycaemic Control in a Metformin-based Therapy of Type 2 Diabetes Mellitus Patients Managed Under Ambulatory Care Settings
Background: Short term clinical outcomes evaluation of glycaemic goals or its control are desirable to monitor response to therapy in individual patients and to identify compliance or other problem areas. Aim and Objecti...
Evaluation of Ampicillin and Ceftriaxone on Ethanol Consumption as Compared to Naltrexone in Alcohol Dependant Rats
Context: Extracellular glutamate level in reward centre of brain increases during ethanol drinking sessions. Hence, it can be hypothesized that drugs which decrease extracellular glutamate might have deaddictive properti...
Design and Evaluation of a New Fixed-Dose Immediate Release Capsule of Atenolol, Enalapril Maleate and Hydrochlorothiazide
Aim and Objectives: To design, formulate and perform in vitro studies of a fixed dose combination (FDC) immediate release solid dosage form of the antihypertensive drugs atenolol, enalapril and hydrochlorothiazide. The o...